Expression, regulation and function of autotaxin in thyroid carcinomas

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Autotaxin (ATX/NPP2) is a secreted enzyme with nucleotide pyrophosphatase/phosphodiesterase and lysophospholipase D activities.
• ATX is known to stimulate tumor cell motility, but its specific role in thyroid carcinoma remains largely uncharacterized.

Purpose of the Study:

• To investigate the expression and function of ATX in various types of thyroid carcinoma.
• To determine the potential of ATX as a diagnostic marker and therapeutic target in thyroid cancer.

Main Methods:

• Quantification of ATX mRNA expression in thyroid carcinoma cell lines and patient tissues.
• Stimulation of ATX expression using growth factors and cytokines.
• Stable transfection of thyroid carcinoma cells to overexpress ATX.
• Assessment of cell proliferation, migration, and gene expression changes (CD54, IL-8) in response to ATX modulation.

Main Results:

• ATX mRNA expression was significantly higher in undifferentiated anaplastic thyroid carcinoma (UTC) compared to follicular thyroid carcinoma (FTC) and goiter tissues.
• Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) increased ATX mRNA, while IL-4, IL-1beta, and TGF-beta decreased it.
• Overexpression of ATX in FTC cells led to increased proliferation, migration, lysophospholipase D activity, and paracrine motility stimulation.
• ATX overexpression downregulated CD54/ICAM-1 and upregulated pro-angiogenic IL-8 gene expression.

Conclusions:

• ATX is a potential tissue marker for undifferentiated human thyroid carcinoma.
• ATX enhances thyroid carcinoma cell proliferation and migration and may influence tumor angiogenesis.
• Further research is warranted to elucidate the comprehensive role of ATX in thyroid gland physiology and pathology.